RxDoctor Payments Data

Lauren Atkinson

Family · Gaylord, MINPI 1063925246

Payments from drug & device makers

$2,108in general payments, 2019–2025

Across 119 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$704
  • Novo Nordisk$465
  • AstraZeneca$158
  • Lilly USA, LLC$156
  • Otsuka America Pharmaceutical, Inc.$96
  • Boehringer Ingelheim$80
  • plus $449 from 14 others

What the payments were for

  • Food & beverage$2,108100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,108 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide46$83,076
TrulicityDulaglutide67$74,598
MounjaroTirzepatide61$66,900
EliquisApixaban74$64,459
OzempicSemaglutide50$54,858
JardianceEmpagliflozin39$47,529
XareltoRivaroxaban32$46,140
Dupixent PenDupilumab11$38,066
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$37,802
JanuviaSitagliptin Phosphate27$34,500
FarxigaDapagliflozin Propanediol21$25,280
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$18,419
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$18,244
Lantus SolostarInsulin Glargine,hum.Rec.Anlog79$12,650
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen412$8,945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$156$141,498128 claims
Novo NordiskRybelsus, Ozempic$465$137,93496 claims
PfizerEliquis$34$64,45974 claims
Boehringer IngelheimJardiance, Spiriva Respimat$80$52,98650 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$158$49,98071 claims
GSKTrelegy Ellipta, Breo Ellipta$68$43,66366 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.

Other family in Gaylord

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →